RE: Seems a formality now11 Apr 2023 08:10
Avacta already have ODD for soft tissue sarcoma. Dr Tap now enrolling STS patient for Avacta's phase 1 trial.
Active enrolment has now begun for soft tissue sarcoma patients to the phase 1 clinical trial in the US, led by Dr William D. Tap, Chief of the Sarcoma Medical Oncology Service at MSK, and Dr Lee D. Cranmer, Professor at the Clinical Research Division of Fred Hutch Cancer Center